Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
Beam Suntory Inc. (BEAM)
Market is closed
Sector: Beverages
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 2. | Cheyne Capital Jonathan Lourie And Stuart Fiertz | 0 | $0 | 0% | |
| 3. | Water Island Capital John Orrico | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | LionEye Capital Management Stephen V. Raneri | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.74 | 1,500 | Director | 1,600 | 2012-08-14 | Filing | |
| $49.80 | 20,000 | Director | 20,000 | 2011-11-10 | Filing | |
| $52.78 | 1,245,054 | Large Shareholder | 20,818,545 | 2011-08-09 | Filing | |
| $52.67 | 1,543,243 | Large Shareholder | 19,573,491 | 2011-08-08 | Filing | |
| $54.47 | 860,215 | Large Shareholder | 18,030,248 | 2011-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $83.36 | 1,300,000 | Large Shareholder | 13,518,545 | 2014-01-31 | Filing | |
| $83.28 | 6,000,000 | Large Shareholder | 14,818,545 | 2014-01-30 | Filing | |
| $68.21 | 5,587 | Officer | 0 | 2013-11-07 | Filing | |
| $68.45 | 21,154 | Officer | 5,587 | 2013-11-06 | Filing | |
| $66.93 | 6,745 | Officer | 4,864 | 2013-11-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $83 | 0% | |
| 2. | 1 | $54 | 0% |
News See All
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Beam Therapeutics Inc. (NASDAQ:BEAM) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Beam Therapeutics Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end.
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
10 Stocks That Will Change the World
If we were to try and summarize one of the biggest ways how to make money on the stock market, it'd include buying stocks of firms that have changed the world.
15 Best ARK Stocks To Buy Now
Cathie Wood is one of the most polarizing, and prominent figures on Wall Street.
Top 11 CRISPR Stocks To Invest In
Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
14 Best Short-Term Stocks to Invest In
In this article, we will take a look at 14 best short-term stocks to invest in.
Billionaire Hedge Funds
